Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing CD34 Enrichment and Mononuclear (CD3) Addback in High Risk Patients with Sickle Cell Disease (SCD)
Document Type
Abstract
Publication Date
11-2018
DOI
10.1182/blood-2018-162
Journal Title
Blood
Department
Pediatrics
Second Department
Medicine
Third Department
Health Behavior and Community Health
Recommended Citation
Cairo, M. S., Shi, Q., Dozor, A. J., Friedman, D., Moorthy, C. R., Ayello, J., Flower, A. M., Chu, Y., Mahanti, H., Klejmont, L., & Shenoy, S. (2018). Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing CD34 Enrichment and Mononuclear (CD3) Addback in High Risk Patients with Sickle Cell Disease (SCD). Blood, 132 (Suppl. 1), 162. https://doi.org/10.1182/blood-2018-162
COinS
Comments
Please see the work itself for the complete list of authors.